John L. Brottem - May 3, 2023 Form 4 Insider Report for Outset Medical, Inc. (OM)

Signature
John L Brottem
Stock symbol
OM
Transactions as of
May 3, 2023
Transactions value $
-$14,875
Form type
4
Date filed
5/5/2023, 06:13 PM
Previous filing
Mar 21, 2023
Next filing
May 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $13.4K +1.41K +2.3% $9.48 63K May 3, 2023 Direct F1
transaction OM Common Stock Sale -$28.3K -1.41K -2.24% $20.00 61.6K May 3, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.41K -6.66% $0.00 19.8K May 3, 2023 Common Stock 1.41K $9.48 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.
F2 This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.